Navigation Links
New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture
Date:10/10/2008

Leading researchers in academia and industry reveal powerful effects of recombinant lactoferrin (tradename: Lacromin) in mammalian cell culture

leading to a significant boost in productivity.

FORT COLLINS, Colo., Oct. 10 /PRNewswire/ -- A recently published study in the scientific journal In Vitro Cellular & Developmental Biology revealed that recombinant lactoferrin (tradename: Lacromin, see http://www.Lacromin.com) is a strong growth factor for promoting cell growth and cell productivity across a variety of cell lines, including intestinal cells, hybridoma cells, osteoblast cells and embryonic kidney (293) cells.

A global collaborative research effort led to the findings. The study included research conducted by two prestigious international research institutions: University of Auckland in New Zealand and Barts & The London Queen Mary's School of Medicine & Dentistry in London. Also, cell culture industry researchers at the following companies contributed to these findings:

-- HyClone Inc in Logan, Utah;

-- KC Bio in Kansas City, Missouri; and

-- InVitria in Fort Collins, Colorado.

Dr. Ning Huang, Vice President of Research and Development for InVitria, coordinated the study entitled, "Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth (1)."

"In working with research collaborators in the industry and leading academic centers around the world, recombinant lactoferrin has been shown to promote cell growth and productivity in a variety of cell lines and also improves antibody product yields in mammalian cell culture," said Dr. Huang. "Since recombinant lactoferrin is well defined, it is an important component for adapting cells and transitioning cells from serum to animal free and completely defined cell culture media."

"We have discovered that recombinant lactoferrin is an important growth factor in bone cell culture media," said Professor Jillian Cornish, Department of Medicine, Faculty of Health and Medical Sciences at University of Auckland. "Not only did we see improved growth of osteoblasts, but we also found that growth increased with greater amounts of recombinant lactoferrin."

About InVitria (http://www.InVitria.com)

InVitria has developed cell culture media components that enhance productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. InVitria's recombinant human lactoferrin called Lacromin (http://www.Lacromin.com) was utilized in this study.

For more detailed product information requests or to order re-prints of the above-mentioned article contact InVitria by e-mail or phone.

E-mail: info@InVitria.com Phone: 1-800-916-8311

(1) Huang, N. et al. Bioactive recombinant human lactoferrin, derived from

rice, stimulates mammalian cell growth. In Vitro Cellular &

Developmental Biology. September 19, 2008 (E-publication Date).


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Facet Solutions Completes Facet Joint and Disc Replacement Study
2. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
3. Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
4. Emisphere Announces Recruitment Phase III Study for Oral Osteoarthritis Treatment
5. Eklin Medical Surpasses 1,000th RapidStudy(R) Digital Radiography System Installation Featuring Canon DR Technology
6. Oil palm plantations are no substitute for tropical rainforests, a new study shows
7. Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures
8. New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices
9. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
10. Germicidal UVC Lights Improve Clinical Pregnancy Rates for IVF Lab, New Study Finds
11. ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... line of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining ... Chicago. The result of a collaboration among several companies with expertise in toolholding, ...
Breaking Biology Technology:
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):